The 6th meeting of the International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) was held virtually and saw leading experts debate key questions on the optimization and role of transplantation and cellular therapies in the field of hematological malignancies.
View all videos

COSTEM 2021

The 6th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM)
21–24 October 2021 | Virtual Meeting

#TXMPN22 | @harrisoncn1 discusses novel targets and combinations being explored in MPNs:

👉http://ow.ly/70he50KOSG1👈

#MPNsm #HemOnc #BloodCancerAwarenessMonth

We spoke to @anniencowan (@DanaFarber) at #IMS2022, who shared some updates from the PROMISE study, which is screening high-risk individuals for precursor conditions such as MGUS and MGIP:

🎥: http://ow.ly/ibfm50KOSf3

@Myeloma_Society #MMsm #HemOnc #BloodCancerAwarenessMonth

We're pleased to bring you another podcast! 🤩

Join experts Heinz Ludwig & Meral Beksac, who discuss the importance of identifying high-risk myeloma & future therapeutic strategies for this patient population.

🎧: http://ow.ly/2Top50KQC0l

#MMsm #HemOnc #ImmunoOnc

Join us this week in Houston, TX, as we interview experts & bring you exclusive discussions from #SOHO22! 👩‍⚕️👨‍⚕️

You won't want to miss out - follow us @VJHemOnc or visit http://VJHemOnc.com for more!

@SocietyofHemOnc #MMsm #LeuSM #AMLsm #ALLsm #LymSM #MDSsm #MPNsm #CLLsm

Load More...

COSTEM 2021

The 6th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM)
21–24 October 2021 | Virtual Meeting
The 6th meeting of the International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) was held virtually and saw leading experts debate key questions on the optimization and role of transplantation and cellular therapies in the field of hematological malignancies.
View all videos

#TXMPN22 | @harrisoncn1 discusses novel targets and combinations being explored in MPNs:

👉http://ow.ly/70he50KOSG1👈

#MPNsm #HemOnc #BloodCancerAwarenessMonth

We spoke to @anniencowan (@DanaFarber) at #IMS2022, who shared some updates from the PROMISE study, which is screening high-risk individuals for precursor conditions such as MGUS and MGIP:

🎥: http://ow.ly/ibfm50KOSf3

@Myeloma_Society #MMsm #HemOnc #BloodCancerAwarenessMonth

We're pleased to bring you another podcast! 🤩

Join experts Heinz Ludwig & Meral Beksac, who discuss the importance of identifying high-risk myeloma & future therapeutic strategies for this patient population.

🎧: http://ow.ly/2Top50KQC0l

#MMsm #HemOnc #ImmunoOnc

Join us this week in Houston, TX, as we interview experts & bring you exclusive discussions from #SOHO22! 👩‍⚕️👨‍⚕️

You won't want to miss out - follow us @VJHemOnc or visit http://VJHemOnc.com for more!

@SocietyofHemOnc #MMsm #LeuSM #AMLsm #ALLsm #LymSM #MDSsm #MPNsm #CLLsm

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter